Continue taking levothyroxine at your adjusted dose with consistent timing
It is important to note that this mechanism, while biologically plausible, is not yet validated by large-scale controlled trials, and individual results vary considerably depending on baseline melanin levels, skin type, and dosage
The role of glucagon-like peptide 1 (GLP-1) receptor agonists in the prevention and treatment of diabetic kidney disease: insights from the AMPLITUDE-O trial
Long-term side effects of the drug for weight loss management are still relatively unknown, so you should only start taking them after a conversation with your primary care provider
T.DeleeuwS.BoxerJ.BonnefontJ
In February, Lilly won FDA approval for Zepbound in a multidose KwikPen device